ConductScience.org, home

Paper30822331

Detoxification therapy of traditional Chinese medicine for genital tract high-risk human papillomavirus infection: A systematic review and meta-analysis.

Luo M and 5 others. PLoS One, 2019. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Detoxification therapy of traditional Chinese medicine for genital tract high-risk human papillomavirus infection: A systematic review and meta-analysis. Papers, record 30822331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30822331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Detoxification therapy of traditional Chinese medicine for genital tract high-risk human papillomavirus infection: A systematic review and meta-analysis.
PubMed
Journal
PLoS One
PubMed
Year
2019
PubMed
Publication types
Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.76
iCite
Revised in PubMed
2020-03-09
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Luo MMei
2Yu JJiaJie
3Zhu SShuYi
4Huang LLi
5Chen YYu
6Wei SShaoBinhttps://orcid.org/0000-0002-8326-7397

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drugs, Chinese HerbalMajor topic
Medicine, Chinese TraditionalMajor topic
Papillomavirus InfectionsMajor topic
Reproductive Tract InfectionsMajor topic
Female
Humans
Randomized Controlled Trials as Topic

Source PubMed

Download CSV of topics

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123146675Prevalence, incidence and persistence of genital HPV infections in a large cohort of sexually active young women in the Netherlands.Vaccine2013https://conductscience.org/library/papers/23146675PubMed
2264754Cytology of gynecologic condyloma acuminatum.Acta Cytol1977https://conductscience.org/library/papers/264754PubMed
31069445Condylomatous lesions of the cervix and vagina. I. Cytologic patterns.Acta Cytol1976https://conductscience.org/library/papers/1069445PubMed
429284025Clinical management and risk reduction in women with low-grade squamous intraepithelial lesion cytology: A population-based cohort study.PLoS One2017https://conductscience.org/library/papers/29284025PubMed
528124442Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): A systematic review.Int J Cancer2017https://conductscience.org/library/papers/28124442PubMed
628953116Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.J Low Genit Tract Dis2017https://conductscience.org/library/papers/28953116PubMed
715547627Herbs or natural products that protect against cancer growth part three of a four-part series.Oncol Nurs Forum2004https://conductscience.org/library/papers/15547627PubMed
823185761[Therapeutic efficacy of youdujing preparation in treating cervical high-risk human papilloma virus infection patients].Zhongguo Zhong Xi Yi Jie He Za Zhi2012https://conductscience.org/library/papers/23185761PubMed
9236356842012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.Obstet Gynecol2013https://conductscience.org/library/papers/23635684PubMed
1026564504[Natural Outcome of Genital Tract High-risk Human Papillomavirus Infection and Associated Factors among 760 Women].Zhongguo Yi Xue Ke Xue Yuan Xue Bao2015https://conductscience.org/library/papers/26564504PubMed
1117342094High-risk HPV type-specific clearance rates in cervical screening.Br J Cancer2007https://conductscience.org/library/papers/17342094PubMed
1222133884The known unknowns of HPV natural history.J Clin Invest2011https://conductscience.org/library/papers/22133884PubMed
1326695583Practice Bulletin No. 157: Cervical Cancer Screening and Prevention.Obstet Gynecol2016https://conductscience.org/library/papers/26695583PubMed

Download CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
38420364Effect of different interventions on the treatment of high-risk human papillomavirus infection: a systematic review and network meta-analysis.Front Med (Lausanne)2024https://conductscience.org/library/papers/38420364PubMed
37692777Effect of heat-clearing and dampness-eliminating Chinese medicine for high-risk cervical cancer papillomavirus infection: a systematic review and meta-analysis of randomized controlled trials.Front Med (Lausanne)2023https://conductscience.org/library/papers/37692777PubMed
37576405Comparative Efficacy and Safety of Chinese Patent Medicines for Cervical High-risk Human Papillomavirus Infection: A Bayesian Network Meta-analysis.J Cancer2023https://conductscience.org/library/papers/37576405PubMed
34925532Functions of Traditional Chinese Medicine Combined with Recombinant Human Interferon α2b in Cervical Intraepithelial Neoplasias Patients.Evid Based Complement Alternat Med2021https://conductscience.org/library/papers/34925532PubMed
34621324Effect of Psychological Care Combined with Traditional Chinese Medicine on Postoperative Psychological Stress Response in Patients with Advanced Cervical Cancer.Evid Based Complement Alternat Med2021https://conductscience.org/library/papers/34621324PubMed
34603461Clinical Effects of Chinese Herbal Decoction Combined with Basic Chemoradiotherapy and Nursing Intervention in the Treatment of Cervical Cancer and the Effect on Serum CEA, CA125, and TNF-α Levels.Evid Based Complement Alternat Med2021https://conductscience.org/library/papers/34603461PubMed
34070706Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asia.Cancers (Basel)2021https://conductscience.org/library/papers/34070706PubMed
33552075
Nocardia Rubra Cell Wall Skeleton Up-Regulates T Cell Subsets and Inhibits PD-1/PD-L1 Pathway to Promote Local Immune Status of Patients With High-Risk Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia.
Front Immunol2020https://conductscience.org/library/papers/33552075PubMed
32849905Zhidai Decoction Inhibits Cervical Cancer through Regulation of Vaginal Microbiota.Evid Based Complement Alternat Med2020https://conductscience.org/library/papers/32849905PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30822331

GET https://conductscience.org/api/papers/v1/30822331/authors